Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q426010> ?p ?o }
Showing triples 1 to 52 of
52
with 100 triples per page.
- Q426010 subject Q5920511.
- Q426010 subject Q6946376.
- Q426010 subject Q7215494.
- Q426010 subject Q7486806.
- Q426010 subject Q7930599.
- Q426010 subject Q8248726.
- Q426010 subject Q8256025.
- Q426010 abstract "Semagacestat (LY450139) was a candidate drug for a causal therapy against Alzheimer's disease. It was originally developed by Eli Lilly and Élan, and clinical trials were conducted by Eli Lilly. Phase III trials included over 3000 patients, but in August 2010, a disappointing interim analysis, in which semagacestat performed worse than the placebo, led to the trials being stopped.".
- Q426010 atcPrefix "none".
- Q426010 casNumber "425386-60-3".
- Q426010 fdaUniiCode "3YN0602W4W".
- Q426010 iupacName "(2S)-2-hydroxy-3-methyl-N-((1S)-1-methyl-2-{[(1S)-3-methyl-2-oxo-2,3,4,5-tetrahydro-1H-3-benzazepin-1-yl]amino}-2-oxoethyl)butanamide".
- Q426010 pubchem "9843750".
- Q426010 thumbnail Semagacestat_structure.svg?width=300.
- Q426010 wikiPageWikiLink Q11081.
- Q426010 wikiPageWikiLink Q1324860.
- Q426010 wikiPageWikiLink Q14864419.
- Q426010 wikiPageWikiLink Q14865870.
- Q426010 wikiPageWikiLink Q14891871.
- Q426010 wikiPageWikiLink Q1493183.
- Q426010 wikiPageWikiLink Q17912018.
- Q426010 wikiPageWikiLink Q30612.
- Q426010 wikiPageWikiLink Q33123.
- Q426010 wikiPageWikiLink Q3813242.
- Q426010 wikiPageWikiLink Q417667.
- Q426010 wikiPageWikiLink Q54196.
- Q426010 wikiPageWikiLink Q5920511.
- Q426010 wikiPageWikiLink Q632240.
- Q426010 wikiPageWikiLink Q6740853.
- Q426010 wikiPageWikiLink Q6946376.
- Q426010 wikiPageWikiLink Q7215494.
- Q426010 wikiPageWikiLink Q7486806.
- Q426010 wikiPageWikiLink Q7930599.
- Q426010 wikiPageWikiLink Q79749.
- Q426010 wikiPageWikiLink Q8248726.
- Q426010 wikiPageWikiLink Q8256025.
- Q426010 wikiPageWikiLink Q849769.
- Q426010 wikiPageWikiLink Q904082.
- Q426010 wikiPageWikiLink Q9377.
- Q426010 atcPrefix "none".
- Q426010 casNumber "425386".
- Q426010 iupacName "-2".
- Q426010 pubchem "9843750".
- Q426010 unii "3".
- Q426010 type ChemicalSubstance.
- Q426010 type Drug.
- Q426010 type ChemicalObject.
- Q426010 type Thing.
- Q426010 type Q8386.
- Q426010 comment "Semagacestat (LY450139) was a candidate drug for a causal therapy against Alzheimer's disease. It was originally developed by Eli Lilly and Élan, and clinical trials were conducted by Eli Lilly. Phase III trials included over 3000 patients, but in August 2010, a disappointing interim analysis, in which semagacestat performed worse than the placebo, led to the trials being stopped.".
- Q426010 label "Semagacestat".
- Q426010 depiction Semagacestat_structure.svg.